Ob-Gyns Received Considerable Payment From Industry in 2014

Share this content:
Ob-Gyns Received Considerable Payment From Industry in 2014
Ob-Gyns Received Considerable Payment From Industry in 2014

WEDNESDAY, Jan. 20, 2016 (HealthDay News) -- In 2014, obstetrician-gynecologists (ob-gyns) received substantial payments from industry, according to a study published in the February issue of Obstetrics & Gynecology.

Nicole M. Tierney, M.D., from the University of California, San Diego, and colleagues conducted a retrospective study to review all 2014 non-research payments to ob-gyns. Payments were compared with those in other specialties as well as subspecialties within obstetrics and gynecology.

The researchers found that payments to ob-gyns totaled $60,004,472 to 29,783 physician recipients (3.3 percent of the total value transferred in 2014). Half of these payments were for royalties and licensing. In the total number of payments made to a single specialty, obstetrics and gynecology ranked seventh (311,485 payments). In terms of the highest median payment, obstetrics and gynecology was 20th out of 35 specialties ($140). The leading payer to ob-gyns was Medtronic USA, Inc.

"Ob-gyns are listed as having received substantial payments from industry in 2014," the authors write. "Because this information is [publicly] available, we suggest physicians become familiar with payment data and the correction process, keep independent records, and register for updates to most effectively manage perceived, or real, conflicts of interest."

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »